What does an eosinophil count of 24% on a Complete Blood Count (CBC) indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Interpretation of 24% Eosinophils on CBC

A blood eosinophil count of 24% on a CBC is significantly elevated and indicates an underlying eosinophilic disorder that requires further investigation to determine the specific cause.

Normal Values and Classification

  • Normal eosinophil percentage in peripheral blood is 1-3% of total leukocytes 1
  • Eosinophilia is defined as a peripheral blood eosinophil count >0.5 × 10⁹/L 2
  • Severity classification:
    • Mild: 0.5-1.5 × 10⁹/L
    • Moderate: 1.5-5.0 × 10⁹/L
    • Severe: >5.0 × 10⁹/L 2

Potential Causes of Elevated Eosinophils (24%)

Allergic/Atopic Conditions

  • Allergic rhinitis, asthma, or eczema 3
  • Eosinophilic asthma (particularly if counts fluctuate seasonally) 3
  • Chronic rhinosinusitis with nasal polyps 3

Gastrointestinal Disorders

  • Eosinophilic esophagitis (EE) - 10-50% of adults and 20-100% of children with EE have elevated peripheral eosinophil counts 3
  • Other eosinophilic gastrointestinal disorders

Hematologic Disorders

  • Myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRA, PDGFRB, or FGFR1 3
  • Chronic eosinophilic leukemia, not otherwise specified (CEL, NOS) 2
  • Hypereosinophilic syndrome (HES) 2

Parasitic Infections

  • Various helminthic infections can cause marked eosinophilia 4

Other Causes

  • Drug reactions
  • Autoimmune disorders
  • Certain vasculitides (e.g., eosinophilic granulomatosis with polyangiitis)

Recommended Diagnostic Approach

Initial Evaluation

  1. Complete history and physical examination:

    • Focus on allergic symptoms, respiratory symptoms, gastrointestinal complaints
    • Medication review for potential drug reactions
    • Travel history for parasitic infections
    • Skin examination for rashes or lesions
  2. Laboratory testing:

    • Complete blood count with differential (to confirm eosinophilia)
    • Peripheral blood smear (to evaluate blood cell morphology)
    • Comprehensive metabolic panel with liver function tests
    • Serum tryptase (to evaluate mast cell activation)
    • IgE levels (often elevated in allergic disorders) 3
  3. Specialized testing based on clinical suspicion:

    • Stool examination for ova and parasites
    • Allergen-specific IgE testing or skin prick testing 3
    • Molecular testing for tyrosine kinase gene fusions (PDGFRA, PDGFRB) 3
    • ANCA testing if vasculitis is suspected 1

Tissue Evaluation

  • Tissue biopsy may be necessary if organ involvement is suspected:
    • Endoscopy with biopsy for suspected eosinophilic esophagitis 3
    • Nasal endoscopy with biopsy for chronic rhinosinusitis 3
    • Bone marrow aspirate and biopsy for suspected hematologic disorders 2

Clinical Implications and Management

Prognostic Significance

  • Persistent blood eosinophilia correlates with persistent symptoms in some conditions 3
  • The degree of elevation may correlate with disease severity 3
  • In some respiratory infections, eosinophilia may indicate better prognosis 4

Treatment Considerations

  • Treatment depends on the underlying cause:
    • Allergic disorders: antihistamines, corticosteroids, allergen avoidance
    • Eosinophilic esophagitis: proton pump inhibitors, topical corticosteroids, elimination diets 1
    • Hematologic disorders: targeted therapies (e.g., imatinib for PDGFRA/B rearrangements) 3
    • Hypereosinophilic syndrome: corticosteroids, hydroxyurea, interferon-α, or IL-5 antagonists 2

Important Considerations

  • A single elevated eosinophil count should be confirmed with repeat testing 5
  • Eosinophil counts can vary seasonally (up to 20% difference between summer and winter) 5
  • Smoking can decrease eosinophil levels by approximately 23% 5
  • Counts between 150-299 cells/μL show the greatest variability over time 5

Follow-up Recommendations

  • Regular monitoring of blood counts to track response to treatment
  • Evaluation for end-organ damage in cases of persistent eosinophilia
  • Referral to specialists (allergist, hematologist, gastroenterologist) based on suspected etiology

A 24% eosinophil count is markedly elevated and warrants prompt and thorough evaluation to identify the underlying cause and prevent potential end-organ damage.

References

Guideline

Eosinopenia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

A Comprehensive Analysis of the Stability of Blood Eosinophil Levels.

Annals of the American Thoracic Society, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.